At a glance
Does a vitamin D effect on immune cells show that the body’s stress system has improved?
No. A cell’s response to a steroid hormone or medicine is different from the feedback system linking the brain and adrenal glands. The cell experiments did not measure that whole system.
Why can vitamin D change steroid responses in different directions?
The studies used different immune cells, timing and measurements. Adding calcitriol, the active vitamin D hormone, before another treatment can produce a different response from adding both together.
Did the human trial show a clear change in daily cortisol?
In women with relapsing-remitting multiple sclerosis, vitamin D levels rose but the daily cortisol comparisons did not show clear treatment differences. The waking-response result also became uncertain after accounting for starting values.
Read the full article below ↓A vitamin D effect on a glucocorticoid response in a blood-cell culture is not the same finding as an effect on hypothalamic-pituitary-adrenal (HPA) axis feedback. The distinction becomes clearer by following the measurements from the cell experiment to the human hormone study and identifying where the evidence stops.
First identify which response changed
Xystrakis studied regulatory T-cell responses using active calcitriol and dexamethasone. The combination enhanced interleukin-10 (IL-10)-associated activity in the culture system. Calcitriol prevented dexamethasone-associated glucocorticoid receptor downregulation, while IL-10 pretreatment increased receptor expression. These are different observations, not interchangeable descriptions of one receptor increase.
Kassi studied peripheral blood mononuclear cells exposed to calcitriol for 11 days. Adding dexamethasone only for the last two days produced attenuation of selected GILZ gene-expression and receptor-translocation responses. Concurrent exposure did not reproduce the same GILZ effect. The timing, cell mixture and endpoint differed from the T-cell experiment.
The relevant connection to Vitamin D and Hormones is an interaction between responses to signals. Neither experiment measured the coordinated output of the hypothalamus, pituitary and adrenal glands. Nor did either establish that ordinary oral vitamin D3 produces the same cellular exposure as active calcitriol placed directly in culture.
Receptor behaviour is not a central feedback measurement
A receptor can change in abundance or move into the nucleus, and a downstream gene can change expression, without showing how circulating cortisol is regulated. These observations help explain cellular responsiveness within Vitamin D Signalling Pathways. To claim central feedback repair, an experiment would need an appropriate measurement of that feedback in the relevant system.
Cell type matters as well. T cells and mixed peripheral immune-cell preparations are not substitutes for hypothalamic neurons. A finding in one does not prove an identical response in another. The opposing experimental directions therefore support context sensitivity, not a universal increase or decrease in glucocorticoid action.
The small studies also have different replication limits. Xystrakis’s resistant-patient cultures included seven unique donors, with one repeat experiment from the same donor. Kassi reported different replication counts across RNA, protein and microscopy outcomes. Counting every assay as another independent confirmation would overstate the evidence.
A daily cortisol profile answers another question
Rolf’s clinical trial measured salivary cortisol across the day and after awakening in women with relapsing-remitting multiple sclerosis. Supplementation changed vitamin D status, but the daily cortisol and slope comparisons were null. The awakening-response comparison weakened after baseline adjustment.
These findings address selected outputs relevant to Vitamin D and the HPA Axis. They do not provide a direct dexamethasone feedback test, an adrenocorticotropic hormone (ACTH) response or a receptor-level explanation. Even a convincing change in a daily profile would still need careful interpretation before being called restoration of the entire feedback system.
Vitamin D, Cortisol and Glucocorticoid Responses: Full Study compares the full experimental and clinical evidence. The useful bridge is a sequence of questions: which cells received which ligand, which response changed, whether that response occurs in the central system, and whether a measured feedback or clinical outcome follows. The cited studies answer some of those questions, but not the whole sequence.
Conclusion
Peripheral glucocorticoid experiments establish bounded cellular interactions. Human cortisol sampling establishes a different kind of evidence. Connecting them helps define the next scientific question, but does not itself demonstrate a completed mechanism or a treatment for stress-related illness. This explanation reports research without recommending the experimental exposures for personal use.
Primary source and publication details
Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, Adikibi T, Pridgeon C, Dallman M, Loke TK, Robinson DS, Barrat FJ, O’Garra A, Lavender P, Lee TH, Corrigan C, Hawrylowicz CM. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. The Journal of clinical investigation. 2006;116(1):146-155. DOI 10.1172/jci21759. PMID 16341266.
Kassi E, Nasiri-Ansari N, Spilioti E, Kalotychou V, Apostolou PE, Moutsatsou P, Papavassiliou AG. Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells. Cellular and molecular life sciences : CMLS. 2016;73(22):4341-4354. DOI 10.1007/s00018-016-2281-3. PMID 27220430.
Rolf L, Damoiseaux J, Huitinga I, Kimenai D, van den Ouweland J, Hupperts R, Smolders J. Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis. Frontiers in neurology. 2018;9:263. DOI 10.3389/fneur.2018.00263. PMID 29755397.
Related reading
A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
This study aimed to investigate the relationship between vitamin D receptor fok1 (VDR fok1) and thymidylate synthase (TYMS) gene polymorphisms with the glucocorticoid (GC) induced osteonecrosis (ON) in Egyptian pediatric ALL patients.
Original paper ↗Read more →Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
Objectives: This study aimed to provide reliable information on the impact of low-dose glucocorticoids (GCs) on the bone mineral density (BMD) of patients with rheumatoid arthritis (RA).
Original paper ↗Read more →Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
The study design employed is distinctive from previous works and aimed to optimize the chances of the candidates to be validated in confirmatory studies and, eventually, to play a useful role in the clinical practice.
Original paper ↗Read more →Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry †
Objective: To determine whether oral vitamin D supplementation reduces the risk of glucocorticoid (GC)-associated severe adverse events (SAEs) in patients with giant cell arteritis (GCA) included in the Spanish ARTESER registry.
Original paper ↗Read more →Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study
We evaluated the long-term effects of once-daily DR-HC on bone in PAI and SAI.
Original paper ↗Read more →Endocrinologic Dysfunctions and Neuropsychiatric Sequelae in Pediatric Patients With a History of Central Nervous System Infection (ENDLESS): A Prospective Monocentric Study
The participants were selected based on a coded diagnosis of CNS infection and had completed their follow-up at the Pediatric Endocrinology Day Hospital after October 2019.
Original paper ↗Read more →Glucocorticoid-centered drug spectrum of non-jaw osteonecrosis, a FAERS pharmacovigilance study with independent validation in Canada Vigilance and JADER
To distinguish jaw misclassification and litigation-related reporting from non-jaw osteonecrosis signals and define their reproducible spectrum.
Original paper ↗Read more →Hair cortisol in polycystic ovary syndrome
The aim of the study was to evaluate adrenal axis hyperactivation measuring hair cortisol levels, and its influence on the relationship among metabolic parameters, inflammation markers and androgens in adult women with PCOS.
Original paper ↗Read more →In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling
This study aimed to investigate the interplay between the GR: and VitD receptor (VDR) signaling.
Original paper ↗Read more →No requirement of perioperative glucocorticoid replacement in patients with endogenous Cushing’s syndrome: a pilot study
Surgical therapy represents the first-line treatment for endogenous Cushing’s syndrome (CS).
Original paper ↗Read more →Prevalence of osteoporosis and osteopenia in elderly patients scheduled for total knee arthroplasty
As there is no investigation of bone mineral density (BMD) in elderly patients prior to total knee arthroplasty (TKA) in Europe, we investigated this issue with a particular focus on a potential treatment gap.
Original paper ↗Read more →Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
The present study aimed to evaluate the impact of the inflammatory process and glucocorticoid treatment on aortic arterial stiffness and body composition in PMR/GCA.
Original paper ↗Read more →Prognostic Value of CRP/25 OH Vitamin D Ratio for Glucocorticoid Efficacy in Acute Severe Ulcerative Colitis Patients
Our study aimed to create a new ASUC algorithm to predict corticosteroid response in the early course of the disease.
Original paper ↗Read more →Reverse Effect of Mammalian Hypocalcemic Cortisol in Fish: Cortisol Stimulates Ca2+ Uptake via Glucocorticoid Receptor-Mediated Vitamin D3 Metabolism
Cortisol was reported to downregulate body-fluid Ca2+ levels in mammals but was proposed to show hypercalcemic effects in teleostean fish.
Original paper ↗Read more →ROLE OF DIFFERENT HORMONES IN THE PATHOGENESIS AND SEVERITY OF ADOLESCENT IDIOPATHIC SCOLIOSIS
To evaluate the hormonal profile of patients with adolescent idiopathic scoliosis (AIS) and its relationship to the severity of the curvature and quality of life.
Original paper ↗Read more →Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database
Background and Objectives: It is crucial to prevent osteoporosis in patients receiving long-term glucocorticoid (GC) treatment.
Original paper ↗Read more →Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis
Multiple sclerosis (MS) has been associated with both a poor vitamin D status and hyperactivity of the hypothalamus: pituitary: adrenal (HPA) axis.
Original paper ↗Read more →The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial
This study aimed to compare the effects of denosumab on bone mineral density (BMD) and bone turnover markers to those of alendronate in patients with GIOP.
Original paper ↗Read more →Therapeutic potential of hydroxybenzoic acid and lentinan in mitigating glucocorticoid-induced osteoporosis: an experimental study
The present study aimed to elucidate the therapeutic efficacy and mechanistic roles of Hydroxybenzoic Acid and Lentinan in counteracting glucocorticoid-induced osteoporosis (GIOP) in mice, with a focus on bone metabolism, inflammation, and oxidative stress pathways.
Original paper ↗Read more →Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study
Intravenous glucocorticoids (IVGC) represent first-line therapy for active moderate-to-severe thyroid-associated ophthalmopathy (TAO).
Original paper ↗Read more →Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis
We investigated the potential of vitamin D (VD) to enhance GC efficacy and the mechanisms underlying this VD/GC interaction.
Original paper ↗Read more →Original sources
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients
Published in The Journal of clinical investigation (2006).
Publication details
Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, Adikibi T, Pridgeon C, Dallman M, Loke TK, Robinson DS, Barrat FJ, O’Garra A, Lavender P, Lee TH, Corrigan C, Hawrylowicz CM. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. The Journal of clinical investigation. 2006;116(1):146-155. DOI 10.1172/jci21759. PMID 16341266.
Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells
Published in Cellular and molecular life sciences : CMLS (2016).
Publication details
Kassi E, Nasiri-Ansari N, Spilioti E, Kalotychou V, Apostolou PE, Moutsatsou P, Papavassiliou AG. Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells. Cellular and molecular life sciences : CMLS. 2016;73(22):4341-4354. DOI 10.1007/s00018-016-2281-3. PMID 27220430.
Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis
Multiple sclerosis (MS) has been associated with both a poor vitamin D status and hyperactivity of the hypothalamus: pituitary: adrenal (HPA) axis.
Publication details
Rolf L, Damoiseaux J, Huitinga I, Kimenai D, van den Ouweland J, Hupperts R, Smolders J. Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis. Frontiers in neurology. 2018;9:263. DOI 10.3389/fneur.2018.00263. PMID 29755397.